AGL (Agilon Health, Inc.) Stock Financials & Earnings

AGLAgilon Health, Inc.

Mkt Cap$256M

Revenue (TTM)$5.9B

Net Income (TTM)-$391M

EPS (TTM)-$0.95

Free Cash Flow (TTM)-$140M

Gross Margin-2.9%

Op. Margin-7.1%

Net Margin-6.6%

FCF Margin-2.4%

P/S Ratio (TTM)0.0x

P/E Ratio (TTM)—

YoY Rev Growth-2.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$1.1B	$73M	$417K
Q2 23	$1.1B	$55M	-$29M
Q3 23	$1.1B	$37M	-$39M
Q4 23	$816M	-$95M	-$160M
Q1 24	$1.6B	$75M	-$7M
Q2 24	$1.5B	$32M	-$43M
Q3 24	$1.5B	-$64M	-$134M
Q4 24	$1.5B	-$38M	-$108M
Q1 25	$1.5B	$51M	-$22M
Q2 25	$1.4B	-$52M	-$116M
Q3 25	$1.4B	-$75M	-$127M
Q4 25	$1.6B	-$98M	-$156M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Quarter	Medical Services Revenue	Other Operating Revenue	Medical Services	Other Operating
Q1 24	$1.6B	$3M	—	—
Q2 24	—	—	$1.5B	$3M
Q3 24	—	—	$1.4B	$3M
Q1 25	—	—	$1.5B	$3M
Q2 25	—	—	$1.4B	$3M
Q3 25	—	—	$1.4B	$3M
Q4 25	—	—	$1.6B	$3M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$394M	$422M	$817M
Q2 23	$191M	$389M	$580M
Q3 23	$168M	$396M	$564M
Q4 23	$114M	$381M	$495M
Q1 24	$119M	$307M	$426M
Q2 24	$116M	$292M	$408M
Q3 24	$154M	$245M	$399M
Q4 24	$194M	$212M	$406M
Q1 25	$139M	$230M	$369M
Q2 25	$171M	$156M	$327M
Q3 25	$172M	$139M	$311M
Q4 25	$174M	$111M	$285M

Shares Outstanding

Revenue Per Employee

Revenue / Employee